ZEKMEDOR

Bristol-Myers Squibb Company

Application Filed: 2004-12-17

Trademark Application Details

Status

605

Dead/Abandoned

ABANDONED – EXPRESS AFTER PUB

Research	OneLook Acronym Finder
Serial Number	78534204
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Nadine P. Flynn
Law Office Assigned	L10
Employee Name	MAYES, LAURIE ANN

Timeline

2004-12-17	Application Filed
2005-11-29	Published for Opposition
2006-02-21	Location: INTENT TO USE SECTION
2008-07-25	Abandon
2008-07-25	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Bristol-Myers Squibb Company
Address	345 Park Avenue New York DE 10154
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARK DEPARTMENT
345 PARK AVENUE
NEW YORK, NY 10154

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents

Type Code

Type

GS0051

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2004-12-29	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2005-04-17	2 DOCK D:Assigned to Examiner
PRIORITY ACTION WRITTEN	2005-04-25	3 CPRA R:Renewal
PRIORITY ACTION MAILED	2005-04-26	4 CPRA F:First Action
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2005-09-12	5 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2005-09-12	6 CRFA I:Incoming Correspondence
AMENDMENT FROM APPLICANT ENTERED	2005-09-17	7 ACEC I:Incoming Correspondence
EXAMINERS AMENDMENT -WRITTEN	2005-09-19	8 CNEA R:Renewal
EXAMINERS AMENDMENT MAILED	2005-09-19	9 CNEA O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2005-09-19	10 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2005-10-05	11 CNSA P:
ASSIGNED TO LIE	2005-10-07	12 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2005-10-07	13 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2005-11-09	14 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2005-11-29	15 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	2006-02-21	16 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2006-05-03	17 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2006-05-03	18 EXT1 S:
EXTENSION 1 GRANTED	2006-05-03	19 EX1G S:
TEAS EXTENSION RECEIVED	2007-01-09	20 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2007-01-09	21 EXT2 S:
EXTENSION 2 GRANTED	2007-01-09	22 EX2G S:
TEAS EXTENSION RECEIVED	2007-07-16	23 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2007-07-16	24 EXT3 S:
EXTENSION 3 GRANTED	2007-07-16	25 EX3G S:
TEAS EXTENSION RECEIVED	2007-12-07	26 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2007-12-07	27 EXT4 S:
EXTENSION 4 GRANTED	2007-12-07	28 EX4G S:
TEAS EXPRESS ABANDONMENT RECEIVED	2008-07-25	29 EXAR I:Incoming Correspondence
ABANDONMENT - AFTER PUBLICATION	2008-07-25	30 ABN5 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	2008-07-25	31 MAB5 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.